Cystadrops® (cysteamine hydrochloride 0.55% viscous eye-drops solution) in treating corneal cystine crystal deposits in patients with cystinosis: a profile of its use
暂无分享,去创建一个
[1] C. Baudouin,et al. A New Viscous Cysteamine Eye Drops Treatment for Ophthalmic Cystinosis: An Open-Label Randomized Comparative Phase III Pivotal Study. , 2017, Investigative ophthalmology & visual science.
[2] I. Kozák,et al. Efficacy of topical cysteamine in nephropathic cystinosis , 2017, British Journal of Ophthalmology.
[3] J. Jester,et al. Synergistic Cysteamine Delivery Nanowafer as an Efficacious Treatment Modality for Corneal Cystinosis. , 2016, Molecular pharmaceutics.
[4] B. Radojković. Cysteamine eye drops in the treatment of cystinosis – an Australian perspective , 2015 .
[5] K. Ramaesh,et al. Treatment of corneal cystine crystal accumulation in patients with cystinosis , 2014, Clinical ophthalmology.
[6] G. Deschênes,et al. A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: the Cystadrops OCT-1 study. , 2014, Molecular genetics and metabolism.
[7] W. Gahl,et al. Cystinosis: the evolution of a treatable disease , 2012, Pediatric Nephrology.
[8] J. Jester,et al. Evaluation of topical cysteamine therapy in the CTNS−/− knockout mouse using in vivo confocal microscopy , 2011, Molecular vision.
[9] N. Soliman,et al. Nephropathic cystinosis in children: An overlooked disease. , 2009, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.
[10] Robert Kleta,et al. Pharmacological treatment of nephropathic cystinosis with cysteamine , 2004, Expert opinion on pharmacotherapy.
[11] W. Gahl,et al. Long-term follow-up of well-treated nephropathic cystinosis patients. , 2004, The Journal of pediatrics.
[12] W. Gahl. Early oral cysteamine therapy for nephropathic cystinosis , 2003, European Journal of Pediatrics.
[13] M. Kaiser-Kupfer,et al. A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis , 2003, The British journal of ophthalmology.
[14] E. Kuehl,et al. Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. , 2000, Molecular genetics and metabolism.
[15] E. Kuehl,et al. A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis. , 1998, Molecular genetics and metabolism.
[16] M. Spencer,et al. A randomised placebo-controlled trial of topical cysteamine therapy in patients with nephropathic cystinosis , 1991, Eye.
[17] E. Kuehl,et al. A randomized placebo-controlled trial of cysteamine eye drops in nephropathic cystinosis. , 1990, Archives of ophthalmology.
[18] M. Kaiser-Kupfer,et al. Removal of corneal crystals by topical cysteamine in nephropathic cystinosis. , 1987, The New England journal of medicine.
[19] W. Gahl,et al. Cysteamine depletes cystinotic leucocyte granular fractions of cystine by the mechanism of disulphide interchange. , 1985, The Biochemical journal.
[20] R. Pisoni,et al. Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts. Role in therapeutic cystine removal? , 1985, The Journal of biological chemistry.